{"id":"W2405943329","doi":"10.1007/s10637-016-0364-5","title":"A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"National Institute of Dental and Craniofacial Research; National Institute on Deafness and Other Communication Disorders; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Docetaxel; Medicine; Oncology; Internal medicine; Clinical endpoint; Head and neck squamous-cell carcinoma; Head and neck cancer; Radiation therapy; Cancer; Clinical trial; Phases of clinical research; Chemotherapy; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001537766,0.0001137474,0.0001389528,0.00003842282,0.00008206065,0.000005911978,0.00008083924,0.00005697822,0.00001228086],"category_scores_gemma":[0.00008407801,0.00006131109,0.000042924,0.00009540978,0.0001546927,0.00001007961,0.00004977699,0.00002994531,3.006863e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003316501,"about_ca_system_score_gemma":0.0003100885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002862822,"about_ca_topic_score_gemma":0.0003770336,"domain_scores_codex":[0.9991976,0.00005171646,0.0002397187,0.0002344978,0.0001516979,0.0001247678],"domain_scores_gemma":[0.999494,0.00005015261,0.0001751447,0.000135324,0.0000815692,0.00006377329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04110833,0.001054616,0.0002735489,0.0001266177,0.0001249915,0.00000154497,0.000419442,0.0002596208,0.8262148,0.01042404,0.00145431,0.1185381],"study_design_scores_gemma":[0.4698807,0.02256028,0.002360773,0.001066266,0.0001995521,0.00005079296,0.00009800269,0.0009578999,0.3342362,0.1248841,0.04293846,0.0007670467],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932132,0.0004390782,0.002753064,0.002477029,0.0001258034,0.0009004059,0.00006255486,0.000003479983,0.00002542058],"genre_scores_gemma":[0.988969,0.0001551307,0.008059381,0.000173353,0.00008051752,0.0001818739,0.00008038034,0.00001565373,0.002284732],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4919786,"threshold_uncertainty_score":0.2500194,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01848131406365525,"score_gpt":0.2890376702067251,"score_spread":0.2705563561430698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}